91

News

Cystic fibrosis: questions on the new drug Vertex

Published: 23 July 2014
What:Investors and patients were exuberant when Vertex Pharmaceuticals released results from clinical trials showing that cystic fibrosis (CF) patients’ lung function improved on an experimental two-drug regimen. But two independent teams of scientists, one from 91, published studies showing that the medications interfere with each other, at least when they are administered to human cells in a laboratory dish.

The studies published in the journalScience Translational Medicineraise fundamental questions about how the drugs work in CF patients and also suggest that a different strategy might be more effective.

Expertise:91 prof. Gergely Lukacs, Faculty of Medicine (Physiology), Canada Research Chair in Cystic Fibrosis

Source:

Back to top